SERPINC1 and inflammatory bowel disease: The main physiological thrombin inhibitor, AT-III, was found to be significantly reduced in IBD patients in the present study as it was in some other studies.[10, 25, 42] Our data showed that AT-III levels were significantly lower in the IBD group as compared with the control group.